Detalhe da pesquisa
1.
The combination of Everolimus with Verapamil reduces ovarian weight and vascular permeability on ovarian hyperstimulation syndrome: a preclinical experimental randomized controlled study.
Gynecol Endocrinol
; 32(11): 886-890, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27223459
2.
Everolimus, an mTOR pathway inhibitor, is highly successful on ovarian hyperstimulation syndrome by reducing ovarian weight and progesterone levels: a preclinical experimental randomized controlled study.
Gynecol Endocrinol
; 31(9): 702-7, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26172931
3.
Ovarian hyperstimulation syndrome inhibition by targeting VEGF, COX-2 and calcium pathways: a preclinical randomized study.
Gynecol Endocrinol
; 30(8): 587-92, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24819316
4.
Yolk sac size and embryonic heart rate as prognostic factors of first trimester pregnancy outcome.
Eur J Obstet Gynecol Reprod Biol
; 138(1): 10-3, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-17693010
5.
The role of gene polymorphisms in endometriosis.
Mol Med Rep
; 16(5): 5881-5886, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28901453